Chimerix, Inc.
General ticker "CMRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $230.6M (TTM average)
Chimerix, Inc. follows the US Stock Market performance with the rate: 10.0%.
Estimated limits based on current volatility of 0.1%: low 8.54$, high 8.55$
Factors to consider:
- Earnings expected soon, date: 2025-05-07 bmo
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.18$, 5.65$]
- 2025-12-31 to 2026-12-31 estimated range: [1.49$, 3.87$]
Financial Metrics affecting the CMRX estimates:
- Negative: Non-GAAP EPS, $ of -0.99 <= 0.04
- Negative: Operating cash flow per share per price, % of -28.82 <= 1.79
- Negative: negative Net income
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
Short-term CMRX quotes
Long-term CMRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $33.82MM | $0.32MM | $0.21MM |
| Operating Expenses | $94.21MM | $93.39MM | $96.78MM |
| Operating Income | $-60.39MM | $-93.06MM | $-96.57MM |
| Non-Operating Income | $232.59MM | $10.97MM | $8.18MM |
| R&D Expense | $71.63MM | $68.79MM | $74.57MM |
| Income(Loss) | $172.20MM | $-82.09MM | $-88.39MM |
| Taxes | $0.04MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $172.17MM | $-82.09MM | $-88.39MM |
| Stockholders Equity | $256.86MM | $193.03MM | $121.68MM |
| Inventory | $0.00MM | $0.00MM | $2.41MM |
| Assets | $279.34MM | $212.77MM | $146.01MM |
| Operating Cash Flow | $-46.87MM | $-69.09MM | $-74.98MM |
| Capital expenditure | $0.07MM | $0.09MM | $0.29MM |
| Investing Cash Flow | $70.04MM | $70.60MM | $71.32MM |
| Financing Cash Flow | $-12.72MM | $0.31MM | $7.05MM |
| Earnings Per Share** | $1.97 | $-0.93 | $-0.99 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.